Hexagon Capital Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-157
| Closed | -$1.39K | – | 1112 |
|
|
2025
Q1 | $1.39K | Buy |
157
+19
| +14% | +$169 | ﹤0.01% | 1485 |
|
|
2024
Q4 | $1.89K | Sell |
138
-1,074
| -89% | -$14.7K | ﹤0.01% | 1431 |
|
|
2024
Q3 | $33.2K | Buy |
1,212
+69
| +6% | +$1.89K | 0.01% | 541 |
|
|
2024
Q2 | $28K | Buy |
1,143
+491
| +75% | +$12K | 0.01% | 574 |
|
|
2024
Q1 | $13.9K | Buy |
652
+277
| +74% | +$5.91K | ﹤0.01% | 766 |
|
|
2023
Q4 | $7.18K | Buy |
+375
| New | +$7.18K | ﹤0.01% | 898 |
|